LON/0R2B (LON/0R2B)

London Stock Exchange: LON/0R2B · USD

$234

+2.41 (+1.0%)· Recorded snapshot

Market cap	124.1B
Revenue (ttm)	19.3B
Net income (ttm)	3.3B
EPS (ttm)	$4.59
P/E (trailing)	38.4x
P/E (forward)	25.4x
Dividend	$1.12 (0.64%)
Volume	1,963
Beta	0.80

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 19.3B
Net income (ttm): 3.3B
EPS (ttm): $4.59
P/E (trailing): 38.4x
P/E (forward): 25.4x
Market cap: 124.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E25.4

P25 13.4P50 18.5P75 26.8

Trailing P/E38.4

P25 16.1P50 24.2P75 39.8

ROE8.2

P25 -48.7P50 3.8P75 15.3

ROIC6.6

P25 -35.4P50 4.3P75 12.3

All LON/0R2B indicators

Market & fundamental data

Available fields

246

Groups with data

Currency

USD

Showing 246 of 246 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United States
Country code	UK
Earnings date	2026-10-21
Employees	60,000
Employees change	-3,000
Employees growth	-4.76%
Enterprise value	$140.8B
Exchange	London Stock Exchange
Financial currency	USD
Financial report date	2026-09-25
First seen	2026-05-10
Fiscal year end	December
Founded	1969
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	US2358511028
Last earnings date	2026-10-21
Last refreshed	2026-10-28
Market cap	$124.1B
Price	$234.17
Price currency	USD
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-28
Symbol	lon/0R2B
Website	https://www.danaher.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	34.56x
Average P/E ratio (3Y)	40.42x
Average P/E ratio (5Y)	36.35x
Earnings yield	2.61%
EV/Earnings	42.58x
EV/EBIT	32.94x
EV/EBITDA	21.59x
EV/FCF	32.2x
EV/Sales	7.24x
FCF / EV yield	3.11%
FCF yield	3.53%
Forward P/E	25.39x
Graham number	105.94056
Graham upside	-55.49%
Lynch fair value	$31.73
Lynch upside	-86.67%
P/(FCF - SBC) ratio	30.09x
P/(OCF - SBC) ratio	24.87x
P/B ratio	3.03x
P/E ratio	38.36x
P/FCF ratio	28.36x
P/OCF ratio	23.68x
P/S ratio	6.34x
Price/EBITDA ratio	19.67x
Sector forward P/E	14.52x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	21.97%
EBITDA margin	32.24%
Effective tax rate	10.98%
FCF margin	22.44%
Gross margin	59.36%
Operating margin	21.97%
Pretax margin	18.81%
Profit margin	16.91%
Profit per employee	$55,441
Profitable quarters	56
Profitable years	14
Revenue per employee	$327,808
ROA	4.06%
ROA (5Y)	4.66%
ROCE	6.68%
ROE	8.19%
ROE (5Y)	9.78%
ROIC	6.6%
ROIC (5Y)	8.05%
SBC / revenue	1.28%
Tax / revenue	2.07%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	25.42%
EPS growth (Q)	37.77%
EPS growth (QoQ)	42.25%
EPS growth 10Y	5.5%
EPS growth 3Y	-8.35%
EPS growth 5Y	-4.99%
EPS growth quarters	5
EPS growth years	0
FCF growth	14.15%
FCF growth 3Y	-5.76%
FCF growth 5Y	-4.09%
Gross profit growth	5.11%
Gross profit growth (Q)	12.77%
Gross profit growth 3Y	6.93%
Gross profit growth 5Y	-2.4%
Net income growth	23.64%
Net income growth (Q)	36.01%
Net income growth (QoQ)	41.95%
Net income growth 3Y	-9.66%
Net income growth 5Y	-5.42%
Net income growth quarters	5
Net income growth years	0
OCF growth	8.56%
OCF growth 10Y	5.27%
OCF growth 3Y	-5.34%
OCF growth 5Y	-3.62%
Operating income growth	7.1%
Operating income growth (Q)	10.27%
Operating income growth 3Y	3.87%
Operating income growth 5Y	-6.08%
Revenue growth	5.52%
Revenue growth (Q)	8.28%
Revenue growth (QoQ)	4.61%
Revenue growth 10Y	4.42%
Revenue growth 3Y	6.79%
Revenue growth 5Y	-1.82%
Revenue growth quarters	6
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-855M
Depreciation and amortization	$2B
EBIT	$4.2B
EBITDA	$6.2B
EPS	$4.59
Financing cash flow	$6.3B
Free cash flow	$4.3B
Free cash flow minus SBC	$4.1B
Gross profit	$11.5B
Income taxes	$399.5M
Investing cash flow	$-8.4B
Net borrowing	$7.8B
Net cash flow	$3.1B
Net income	$3.3B
Operating cash flow minus SBC	$4.9B
Operating income	$4.2B
Revenue	$19.3B
Stock-based compensation	$248.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.47
Book value per share	$57.57
Debt / EBITDA	3.24
Debt / equity	0.52
Debt / FCF	4.85
Goodwill	$35.6B
Interest coverage	15.63
Long-term assets	$59.3B
Long-term liabilities	$23.1B
Net cash (debt)	$-16.7B
Net cash / market cap	-13.61%
Net debt / EBITDA	2.68
Net debt / equity	0.41
Net debt / FCF	3.86
Piotroski F-Score	5
Property, plant and equipment	$5.2B
Shareholders' equity	$40.5B
Tangible book value	$-11.1B
Tangible book value per share	$-15.83
Total assets	$70.5B
Total cash	$4.3B
Total debt	$21B
Total liabilities	$29.9B
WACC	7.54%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.3
Current assets	$11.1B
Current liabilities	$6.8B
Current ratio	1.63
Inventory turnover	3.58
Net working capital	$1.6B
Quick ratio	1.19
Working capital	$4.3B
Working capital turnover	4.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.6%
Dividend growth	23.58%
Dividend growth (3Y)	12.77%
Dividend growth (5Y)	13.42%
Dividend growth years	9
Dividend payment date	2026-10-30
Dividend payment years	11
Dividend payout frequency	Quarterly
Dividend per share	$1.12
Dividend yield	0.64%
Ex-dividend date	2026-09-30
Last dividend	$0.40
Payout ratio	23.46%
Shareholder yield	2.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$197.59
1D price change	1.04%
1M price change	4.64%
1M total return	4.83%
1W price change	4.2%
1W total return	4.2%
1Y price change	6.18%
1Y return CAGR	6.97%
1Y total return	6.96%
20-day SMA	$224.32
200-day SMA	$201.13
3M price change	20.28%
3M total return	20.49%
3Y price change	24.38%
3Y return CAGR	8.17%
3Y total return	26.59%
50-day SMA	$217.94
50-day SMA vs 200-day SMA	50over200
52-week high	$244.50
52-week high date	2026-01-22
52-week low	$159.95
52-week low date	2026-05-18
5Y price change	-24.14%
5Y return CAGR	-2.58%
5Y total return	-12.23%
6M price change	29.84%
6M total return	30.33%
All-time high	$333.61
All-time high date	2021-09-10
All-time low	$75.95
All-time low date	2014-11-05
Average true range (ATR)	$8.79
Average volume	1.9K
Beta (5Y)	0.8
Change from 52-week high	-4.22%
Change from 52-week low	46.4%
Change from all-time high	-29.81%
Change from all-time low	208.34%
Change from open	1.37%
Day's gap	-0.32%
Dollar volume	$459,676
High price	$238.00
Low price	$228.98
Monthly RSI	56.95
Open price	$231.00
Position in 52-week range	57.54%
Previous close	$231.75
Price vs 150-day SMA	18.51%
Price vs 20-day SMA	4.39%
Price vs 200-day SMA	16.43%
Price vs 50-day SMA	7.45%
Relative volume	1.06
RSI	64.22
Sharpe ratio	0.25
Sharpe ratio (3Y)	0.16
Sharpe ratio (5Y)	-0.07
Sortino ratio	0.54
Sortino ratio (3Y)	0.44
Sortino ratio (5Y)	0.1
Volume	2K
Weekly RSI	63.17
YTD price change	1.64%
YTD total return	2.24%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	626.3M
Shares change (QoQ)	-0.11%
Shares change (YoY)	-1.6%
Shares held by insiders	10.86%
Shares held by institutions	83.41%
Short ratio	1.9 days

Deeper analysis on LON/0R2B

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this LON/0R2B report

Is a complete LON/0R2B research report available?

No complete published report is available for lon/0R2B (LON/0R2B) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0R2B (LON/0R2B)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0R2B

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0R2B indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0R2B

Frequently asked questions